AppliedVR, a pioneer advancing the next generation of digital medicine, has announced results from the first randomized controlled trial (RCT), evaluating virtual-reality-based (VR) therapy for self-management of chronic pain at home, the company said.
The study, which was published in JMIR-FR, found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.
With the COVID-19 pandemic severely disrupting Americans´ ability to seek care in clinical settings safely, demand for home-based virtual care has skyrocketed, forcing providers, insurers and policymakers to expand access to digital medicine. Today´s study sought to demonstrate the feasibility and efficacy of people using the AppliedVR program at home on themselves to manage their chronic pain. The team conducted a rigorously designed study that compared VR to the same treatment delivered in an audio-only format, and found that VR was superior at delivering on desired outcomes.
The study analyzed data from 74 people who suffer from chronic lower-back or fibromyalgia pain over a 21-day period and showed that participants using AppliedVR´s EaseVR program significantly reduced five key pain indicators – each of which met or exceeded the 30-percent threshold for clinically meaningful.
AppliedVR is pioneering the next generation of digital medicines to deliver safe and effective virtual reality therapeutics (VRx) that address unmet needs and improve clinical outcomes for patients with serious health conditions. To learn more about AppliedVR, Inc., visit: https://appliedvr.io/.